Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CVS Health Corporation CVS

Set alert

Price alert · CVS

All alert types
90.25 USD -0.08 -0.09%

At close · Oct 30

90.25 0.00 0.00%

After hours · Oct 30, 4:33 PM ET

Bid
90.23 × 300
Ask
90.27 × 200
89.90 Day range 91.95
70.08 52-week range 110.60
YTD
+13.72%
1 year
+17.68%
Open
91.95
Prev close
90.33
Mkt cap
115.43B
Vol
8.19M
Avg vol
7.94M
EPS
3.80
P/E
23.75
Div yield
2.94%
More statistics
Low
89.90
High
91.95
Forward P/E
10.60
Beta
0.60
Short ratio
1.63
Inst. own
91.08%
Dividend
2.66
Ex-div date
Oct 21, 2026
Earnings
Nov 4, 2026
50-d avg
91.29
200-d avg
88.73
1y target
115.48

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 6, 2026Earnings: 2.57; estimate 2.18; surprise 17.89%
  • Aug 5, 2026Earnings: 2.58; estimate 1.85; surprise 39.46%
  • Aug 6, 2026Rating: Evercore ISI Group · Outperform → Outperform
  • Aug 6, 2026Rating: UBS · Buy → Buy
  • Nov 4, 2026Earnings: —; estimate 1.65; surprise —%
Signals (50)
NameDateAgo
MACD: Buy SignalFeb 1, 20269 months ago
SMA: BullishAug 1, 20251 year ago
SMA: BullishAug 1, 20251 year ago
MACD: Sell SignalMay 1, 20233 years ago
SMA: BearishFeb 1, 20233 years ago
SMA: BearishFeb 1, 20233 years ago
SMA: BullishMay 1, 20215 years ago
MACD: Buy SignalMay 1, 20215 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BearishFeb 1, 20206 years ago
SMA: BullishNov 1, 20197 years ago
SMA: BearishNov 1, 20188 years ago
SMA: BullishAug 1, 20188 years ago
SMA: BearishFeb 1, 20188 years ago
MACD: Sell SignalNov 1, 201610 years ago
SMA: BearishMay 1, 201610 years ago
RSI: OverboughtNov 1, 201214 years ago
MACD: Buy SignalNov 1, 201115 years ago
SMA: BullishNov 1, 201016 years ago
SMA: BearishMay 1, 201016 years ago
SMA: BullishFeb 1, 201016 years ago
SMA: BearishNov 1, 200917 years ago
SMA: BullishAug 1, 200917 years ago
MACD: Sell SignalNov 1, 200818 years ago
SMA: BearishAug 1, 200818 years ago
RSI: OverboughtAug 1, 200719 years ago
MACD: Buy SignalMay 1, 200422 years ago
SMA: BullishFeb 1, 200422 years ago
SMA: BullishAug 1, 200323 years ago
SMA: BearishAug 1, 200125 years ago
MACD: Sell SignalAug 1, 200125 years ago
SMA: BearishMay 1, 200125 years ago
SMA: BullishAug 1, 200026 years ago
SMA: BearishMay 1, 200026 years ago
SMA: BullishFeb 1, 200026 years ago
SMA: BearishNov 1, 199927 years ago
RSI: OverboughtNov 1, 199729 years ago
MACD: Buy SignalFeb 1, 199729 years ago
SMA: BullishNov 1, 199630 years ago
SMA: BullishFeb 1, 199630 years ago
SMA: BearishNov 1, 199333 years ago
SMA: BearishFeb 1, 199333 years ago
SMA: BullishNov 1, 199135 years ago
SMA: BearishAug 1, 199135 years ago
SMA: BullishNov 1, 199036 years ago
SMA: BearishAug 1, 199036 years ago
RSI: OverboughtMay 1, 199036 years ago
RSI: OverboughtNov 1, 198838 years ago
SMA: BullishNov 1, 198739 years ago
SMA: BearishAug 1, 198739 years ago

Financial health

Altman Z-Score

2.46 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 5
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 2
  • P/B 4

Valuation

P/E 56.7×
FY 2016: 16.0×FY 2017: 11.2×FY 2018: -115×FY 2019: 14.6×FY 2020: 12.5×FY 2021: 17.2×FY 2022: 28.3×FY 2023: 12.2×FY 2024: 12.3×FY 2025: 56.7×
FY 2016 5y median 17.2× FY 2025
P/S 0.3×
FY 2016: 0.5×FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 0.3×FY 2021: 0.5×FY 2022: 0.4×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
P/B 1.3×
FY 2016: 2.3×FY 2017: 2.0×FY 2018: 1.2×FY 2019: 1.5×FY 2020: 1.3×FY 2021: 1.8×FY 2022: 1.7×FY 2023: 1.3×FY 2024: 0.7×FY 2025: 1.3×
FY 2016 5y median 1.3× FY 2025
P/FCF 12.9×
FY 2016: 10.7×FY 2017: 12.1×FY 2018: 10.0×FY 2019: 9.3×FY 2020: 6.7×FY 2021: 8.6×FY 2022: 9.1×FY 2023: 9.8×FY 2024: 8.9×FY 2025: 12.9×
FY 2016 5y median 9.1× FY 2025
EV/EBITDA 18.8×
FY 2016: 8.9×FY 2017: 8.4×FY 2018: 20.4×FY 2019: 11.0×FY 2020: 9.7×FY 2021: 11.6×FY 2022: 14.6×FY 2023: 9.5×FY 2024: 9.6×FY 2025: 18.8×
FY 2016 5y median 11.6× FY 2025
EV/Sales 0.5×
FY 2016: 0.6×FY 2017: 0.5×FY 2018: 0.7×FY 2019: 0.7×FY 2020: 0.6×FY 2021: 0.7×FY 2022: 0.6×FY 2023: 0.5×FY 2024: 0.4×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
FCF Yield 7.8%
FY 2016: 9.4%FY 2017: 8.2%FY 2018: 10.0%FY 2019: 10.8%FY 2020: 15.0%FY 2021: 11.6%FY 2022: 11.0%FY 2023: 10.2%FY 2024: 11.2%FY 2025: 7.8%
FY 2016 5y median 11.0% FY 2025

Profitability

Gross Margin 13.8%
FY 2016: 16.2%FY 2017: 15.4%FY 2018: 16.2%FY 2019: 17.7%FY 2020: 18.3%FY 2021: 17.8%FY 2022: 16.9%FY 2023: 15.2%FY 2024: 13.8%FY 2025: 13.8%
FY 2016 5y median 15.2% FY 2025
Operating Margin 2.6%
FY 2016: 5.8%FY 2017: 5.2%FY 2018: 2.1%FY 2019: 4.7%FY 2020: 5.2%FY 2021: 4.6%FY 2022: 2.5%FY 2023: 3.8%FY 2024: 2.3%FY 2025: 2.6%
FY 2016 5y median 2.6% FY 2025
Net Margin 0.4%
FY 2016: 3.0%FY 2017: 3.6%FY 2018: -0.3%FY 2019: 2.6%FY 2020: 2.7%FY 2021: 2.7%FY 2022: 1.3%FY 2023: 2.3%FY 2024: 1.2%FY 2025: 0.4%
FY 2016 5y median 1.3% FY 2025
ROE 2.4%
FY 2016: 14.4%FY 2017: 17.6%FY 2018: -1.0%FY 2019: 10.4%FY 2020: 10.3%FY 2021: 10.7%FY 2022: 6.0%FY 2023: 10.9%FY 2024: 6.1%FY 2025: 2.4%
FY 2016 5y median 6.1% FY 2025
ROIC 4.7%
FY 2016: 9.1%FY 2017: 11.0%FY 2018: -1.1%FY 2019: 5.1%FY 2020: 5.8%FY 2021: 5.9%FY 2022: 3.6%FY 2023: 5.9%FY 2024: 3.6%FY 2025: 4.7%
FY 2016 5y median 4.7% FY 2025
ROA 0.7%
FY 2016: 5.6%FY 2017: 7.0%FY 2018: -0.3%FY 2019: 3.0%FY 2020: 3.1%FY 2021: 3.4%FY 2022: 1.9%FY 2023: 3.3%FY 2024: 1.8%FY 2025: 0.7%
FY 2016 5y median 1.9% FY 2025

Growth (YoY)

Revenue 7.8%
FY 2016: 15.8%FY 2017: 4.1%FY 2018: 5.3%FY 2019: 32.0%FY 2020: 4.6%FY 2021: 8.7%FY 2022: 10.4%FY 2023: 10.9%FY 2024: 4.2%FY 2025: 7.8%
FY 2016 FY 2025
Operating Income 21.9%
FY 2016: 9.6%FY 2017: -8.2%FY 2018: -57.8%FY 2019: 198.1%FY 2020: 16.1%FY 2021: -4.3%FY 2022: -40.2%FY 2023: 72.8%FY 2024: -38.0%FY 2025: 21.9%
FY 2016 FY 2025
EPS (diluted) -62.0%
FY 2016: 5.8%FY 2017: 31.4%FY 2018: -108.9%FY 2019: 991.2%FY 2020: 7.5%FY 2021: 9.0%FY 2022: -45.2%FY 2023: 98.5%FY 2024: -43.4%FY 2025: -62.0%
FY 2016 FY 2025
Free Cash Flow 23.4%
FY 2016: 28.3%FY 2017: -23.1%FY 2018: 12.1%FY 2019: 52.2%FY 2020: 29.2%FY 2021: 17.3%FY 2022: -14.6%FY 2023: -22.7%FY 2024: -39.1%FY 2025: 23.4%
FY 2016 FY 2025

Financial Health

Current Ratio 0.8×
FY 2016: 1.2×FY 2017: 1.0×FY 2018: 1.0×FY 2019: 0.9×FY 2020: 0.9×FY 2021: 0.9×FY 2022: 0.9×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 0.8×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 0.6×
FY 2016: 0.6×FY 2017: 0.5×FY 2018: 0.7×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
Debt / Equity 1.2×
FY 2016: 0.7×FY 2017: 0.7×FY 2018: 1.3×FY 2019: 1.4×FY 2020: 1.2×FY 2021: 1.0×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 1.1×FY 2025: 1.2×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 8.6×
FY 2016: 2.0×FY 2017: 2.1×FY 2018: 10.3×FY 2019: 5.1×FY 2020: 4.5×FY 2021: 3.8×FY 2022: 4.7×FY 2023: 3.9×FY 2024: 5.4×FY 2025: 8.6×
FY 2016 5y median 4.7× FY 2025
Interest Coverage 3.3×
FY 2016: 9.6×FY 2017: 9.0×FY 2018: 1.5×FY 2019: 3.9×FY 2020: 4.8×FY 2021: 5.3×FY 2022: 3.5×FY 2023: 5.2×FY 2024: 2.9×FY 2025: 3.3×
FY 2016 5y median 3.5× FY 2025

Dividends

Dividend Yield 3.4%
FY 2016: 2.2%FY 2017: 2.8%FY 2018: 3.0%FY 2019: 2.7%FY 2020: 2.9%FY 2021: 1.9%FY 2022: 2.4%FY 2023: 3.1%FY 2024: 6.0%FY 2025: 3.4%
FY 2016 5y median 3.1% FY 2025
Payout Ratio 192.1%
FY 2016: 34.6%FY 2017: 30.9%FY 2018: -343.1%FY 2019: 39.2%FY 2020: 36.6%FY 2021: 32.8%FY 2022: 67.4%FY 2023: 37.5%FY 2024: 73.1%FY 2025: 192.1%
FY 2016 5y median 67.4% FY 2025

Annual · latest fiscal year ends 2025-12-31